2.43
price down icon4.71%   -0.12
after-market Dopo l'orario di chiusura: 2.25 -0.18 -7.41%
loading
Precedente Chiudi:
$2.55
Aprire:
$2.64
Volume 24 ore:
35,708
Relative Volume:
0.10
Capitalizzazione di mercato:
$3.64M
Reddito:
-
Utile/perdita netta:
$-6.78M
Rapporto P/E:
-0.0569
EPS:
-42.6996
Flusso di cassa netto:
$-4.67M
1 W Prestazione:
+34.25%
1M Prestazione:
-51.59%
6M Prestazione:
-94.14%
1 anno Prestazione:
-95.78%
Intervallo 1D:
Value
$2.355
$2.64
Intervallo di 1 settimana:
Value
$1.84
$2.74
Portata 52W:
Value
$1.743
$64.80

Clearmind Medicine Inc Stock (CMND) Company Profile

Name
Nome
Clearmind Medicine Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
1
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CMND's Discussions on Twitter

Confronta CMND con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CMND
Clearmind Medicine Inc
2.43 3.82M 0 -6.78M -4.67M -42.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.68 122.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
801.01 85.37B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
399.40 55.82B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
795.57 50.67B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
170.27 37.54B 447.02M -1.18B -906.14M -6.1812

Clearmind Medicine Inc Borsa (CMND) Ultime notizie

pulisher
Jan 08, 2026

Published on: 2026-01-09 01:57:04 - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Clearmind Medicine Inc. stock remains on buy listsJuly 2025 Action & Real-Time Sentiment Analysis - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Clearmind Medicine Inc. stock deliver shareholder valueTrade Analysis Report & High Accuracy Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Does Clearmind Medicine Inc. (CWY0) stock trade below intrinsic valueQuarterly Investment Review & Scalable Portfolio Growth Methods - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Will Clearmind Medicine Inc. stock benefit from AI adoptionStock Buy Signals & Target Triple-Digit Stock Opportunities - ulpravda.ru

Jan 07, 2026
pulisher
Jan 07, 2026

Surprises Report: Why Clearmind Medicine Inc stock is recommended by analystsChart Signals & Safe Swing Trade Setups - moha.gov.vn

Jan 07, 2026
pulisher
Jan 06, 2026

How geopolitical tensions affect Clearmind Medicine Inc. stock2026 world cup usa national team group stage defensive leaders possession football match prediction insights - ulpravda.ru

Jan 06, 2026
pulisher
Jan 06, 2026

Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stockStop Loss Placement Tips & Build Wealth With Zero-Cost Tools - bollywoodhelpline.com

Jan 06, 2026
pulisher
Jan 05, 2026

Portfolio Shifts: Why Clearmind Medicine Inc stock is recommended by analystsRate Cut & Reliable Price Action Trade Plans - moha.gov.vn

Jan 05, 2026
pulisher
Dec 31, 2025

Clearmind Medicine Announces the Notice of an International Patent App... - Moscow-Pullman Daily News

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind Medicine regains compliance with NASDAQ minimum bid price rule - MSN

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind regains Nasdaq compliance as shares maintain $1 minimum - Investing.com India

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind Medicine Says Nasdaq Compliance Regained on Minimum Bid Price Rule - MarketScreener

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind Medicine regains compliance with Nasdaq minimum bid price rule - TipRanks

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind regains Nasdaq compliance as shares maintain $1 minimum By Investing.com - Investing.com South Africa

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative

Dec 31, 2025
pulisher
Dec 31, 2025

Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement - marketscreener.com

Dec 31, 2025
pulisher
Dec 25, 2025

Clearmind Medicine highlights key 2025 achievements - MSN

Dec 25, 2025
pulisher
Dec 24, 2025

Clearmind advances AUD treatment as phase I/IIa trial progresses By Investing.com - Investing.com Nigeria

Dec 24, 2025
pulisher
Dec 24, 2025

Clearmind advances AUD treatment as phase I/IIa trial progresses - Investing.com

Dec 24, 2025
pulisher
Dec 24, 2025

Clearmind Medicine Inc. Reflects on Major Progress in 2025 Clinical Trials for CMND-100 Targeting Alcohol Use Disorder - Quiver Quantitative

Dec 24, 2025
pulisher
Dec 24, 2025

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth - Yahoo Finance

Dec 24, 2025
pulisher
Dec 24, 2025

Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - MSN

Dec 24, 2025
pulisher
Dec 21, 2025

Cash from operating activities of Clearmind Medicine Inc. – MUN:CWY - TradingView — Track All Markets

Dec 21, 2025
pulisher
Dec 20, 2025

Trading Recap: How strong is Clearmind Medicine Inc. stock balance sheetJuly 2025 Selloffs & Weekly Setup with ROI Potential - moha.gov.vn

Dec 20, 2025
pulisher
Dec 20, 2025

How interest rate cuts could boost Clearmind Medicine Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Clearmind Medicine Inc. (NASDAQ: CMND)Share Price - intelligentinvestor.com.au

Dec 19, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-19 05:54:25 - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Pretax income of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - MSN

Dec 18, 2025
pulisher
Dec 18, 2025

Free float of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Cash from financing activities of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Cost of goods sold of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Gross profit of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

EBIT of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

EBIT per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Diluted earnings per share (diluted EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Long term debt to total assets ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Non-operating income (total) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Operating expenses (excl. COGS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Clearmind Medicine Inc. Balance Sheet – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Price to cash flow ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Diluted net income available to common stockholders of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Operating cash flow per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

CapEx per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Enterprise value to EBITDA ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Operating margin % of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Total revenue of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-18 16:01:28 - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Clearmind Medicine Inc. Cash Flow – LSX:A41YK5 - TradingView — Track All Markets

Dec 18, 2025

Clearmind Medicine Inc Azioni (CMND) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Capitalizzazione:     |  Volume (24 ore):